The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...

The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

The new data from the US Measles Tracker, hosted by the International Vaccine Access Center (IVAC) at the Johns Hopkins ...

New Evidation CEO Leslie Olay Wilberforce speaks at a Reuters event earlier this year. Earlier this year, San Francisco-based ...

Health technology assessment (HTA) agency NICE has published final draft guidance for IL-23 inhibitor Omvoh (mirikizumab), ...

Back for its second year, the ADC Partnering & Investment Summit unites 100+ top ADC companies, pharma leaders, and investors ...

The Immune Cell Engager Partnering & Investment Summit is here. As part of the game-changing Partnering & Investment Series, ...